Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute gives an overview of his abstract, Inhibition of AURKA induces Raf1-independent activation of MAPK pathway in breast cancer cells, which was presented at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.